Doris Pharmaceuticals: Suspension of trading from the 29th for the planned change of ownership control.

Doray Medicine announced on September 28 that the controlling shareholder, Tibet Jiakang Times Technology Development Co., Ltd., and the actual controller Deng Yong are planning for changes in the company's ownership. This may lead to changes in the controlling shareholder and the actual controller. Upon application, the company's stock will be suspended from trading starting on September 29, and the suspension is expected to last for no more than 2 trading days.